Formulation of injectable glycyrrhizic acid-hydroxycamptothecin micelles as new generation of DNA topoisomerase I inhibitor for enhanced antitumor activity

Jieying Cai(Nanfang Hospital), Guofeng Li(Shenzhen University), Shiwen Luo(Southern Medical University), Boxin Zhao(Nanfang Hospital), Qing Zhang(AIL Research (United States)), Yingguang Deng(Nanfang Hospital), Hongyuan Huang(Nanfang Hospital), Xueli Lv(Southern Medical University)
International Journal of Pharmaceutics
September 13, 2019
Cited by 45


Related Papers